Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Pabinger-Fasching, I; Eichinger-Hasenauer, S; Grohs, J; Hochreiter, J; Kastner, N; Korninger, HC; Kozek-Langenecker, S; Marlovits, S; Niessner, H; Rachbauer, F; Ritschl, P; Wurnig, C; Windhager, R.
[Prevention of venous thromboembolism in musculoskeletal surgery].
Wien Klin Wochenschr. 2014; 126(9-10):298-310 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Autor/innen der Med Uni Graz:
Kastner Norbert
Altmetrics:

Dimensions Citations:

Plum Analytics:
Abstract:
Musculoskeletal surgery is associated with a high risk of venous thrombosis and pulmonary embolism. The introduction of direct oral anticoagulants (DOAK) has broadened the possibilities for prevention of venous thromboembolism in the course of orthopedic and trauma surgery. Addressing this recent development, the Austrian Societies of Orthopedics and Orthopedic Surgery (ÖGO), Trauma Surgery (ÖGU), Hematology and Oncology (OeGHO) and of Anaesthesiology, Reanimation und Intensive Care Medicine (ÖGARI) have taken the initiative to create Austrian guidelines for the prevention of thromboembolism after total hip and knee replacement, hip fracture surgery, interventions at the spine and cases of minor orthopedic and traumatic surgery. Furthermore, the pharmacology of the DOAK and the pivotal trial data for each of the three currently available substances - apixaban, dabigatran, and rivaroxaban - are briefly presented. Separate chapters are dedicated to "anticoagulation and neuroaxial anesthesia" and "bridging".
Find related publications in this database (using NLM MeSH Indexing)
-
Hematology - standards
Orthopedic Procedures - adverse effects
Orthopedic Procedures - standards
Orthopedics - standards
Practice Guidelines as Topic -
Venous Thromboembolism - etiology
Venous Thromboembolism - prevention & control

Find related publications in this database (Keywords)
Venous thromboembolism
Prevention of thromboembolism
New oral anticoagulants
Orthopedics
Bridging
Apixaban
Dabigatran
Rivaroxaban
© Meduni Graz Impressum